Deutsche Bank AG Has $754.93 Million Holdings in Agilent Technologies, Inc. $A

Deutsche Bank AG lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 0.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,548,091 shares of the medical research company’s stock after selling 29,319 shares during the quarter. Deutsche Bank AG’s holdings in Agilent Technologies were worth $754,929,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of A. Bridgefront Capital LLC acquired a new stake in shares of Agilent Technologies during the third quarter worth approximately $1,323,000. Wellington Management Group LLP boosted its holdings in shares of Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after purchasing an additional 433,342 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Agilent Technologies by 4.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after purchasing an additional 24,687 shares during the period. Generation Investment Management LLP boosted its holdings in shares of Agilent Technologies by 10.1% during the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after purchasing an additional 582,093 shares during the period. Finally, Champlain Investment Partners LLC boosted its holdings in shares of Agilent Technologies by 33.3% during the third quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company’s stock worth $114,972,000 after purchasing an additional 223,750 shares during the period.

Analysts Set New Price Targets

A has been the subject of several research reports. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. UBS Group decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. HSBC decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Royal Bank Of Canada initiated coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target for the company. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $161.71.

Agilent Technologies Trading Up 2.0%

Shares of NYSE A opened at $135.39 on Wednesday. The stock has a market cap of $38.24 billion, a price-to-earnings ratio of 27.19, a PEG ratio of 2.36 and a beta of 1.26. The business has a 50 day simple moving average of $119.23 and a 200 day simple moving average of $128.09. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The business had revenue of $1.84 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.99 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.